Blueshift Asset Management, LLC Mirati Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$36.54 - $54.26 $297,983 - $442,490
8,155 New
8,155 $303,000
Q3 2022

Nov 14, 2022
BUY
$59.5 - $86.7 $221,221 - $322,350
3,718 New
3,718 $260,000
Q1 2021

May 06, 2021
SELL
$158.92 - $221.61 $277,315 - $386,709
-1,745 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$162.05 - $240.27 $282,777 - $419,271
1,745 New
1,745 $383,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email